Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Vomiting 37 Nausea 25 Neoplasms 12 Breast Neoplasms 6 Lymphoma 3 Stomach Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Rectal Neoplasms 2 Multiple Myeloma 2 Lymphoma, Non-Hodgkin 2 Leukemia 2 Hematologic Neoplasms 2 Colorectal Neoplasms 2 Colonic Neoplasms 2 Breast Neoplasms, Male 2 Weight Loss 1 Solid Tumors 1 Sarcoma 1 Radiation Injuries 1 Pancreatic Neoplasms 1 Pain 1 Neoplasms, Germ Cell and Embryonal 1 Nausea With Vomiting Chemotherapy-Induced 1 Melanoma 1 Lung Neoplasms 1 Liver Neoplasms 1 Leukemia, Myeloid, Acute 1 Inflammatory Breast Neoplasms 1 Hematologic Diseases 1 Glioma 1

Interventions

Fentanyl 27 Analgesia 23 Morphine 20 Acupuncture Therapy 18 Surveys and Questionnaires 16 Oxycodone 16 Zoledronic Acid 15 Acetaminophen 14 Therapeutics 13 Radiotherapy 13 Psychiatric Rehabilitation 13 Ketamine 13 Methadone 11 Lidocaine 11 Hydromorphone 11 Bupivacaine 11 nabiximols 10 Ibandronic Acid 10 Ropivacaine 9 Early Intervention, Educational 7 Analgesics, Opioid 7 Saline Solution 6 Music Therapy 6 Cryotherapy 6 Cryosurgery 6 Yoga 5 Water 5 Tapentadol 5 Pregabalin 5 Methods 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Pain × Palonosetron × Clear all

NCT05315999 2025-03-19

ProTreat

University Hospital Freiburg

Phase 2 Completed

Nausea, Pain, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon ⚡